The predictive value of PD-L1 diagnostics (vol 39, pg 498, 2018)

被引：0
|
作者：
Schildhaus, H. -U. [1 ]
机构：
[1] Univ Klinikum Essen AoR, Inst Pathol, Hufelandstr 55, D-45147 Essen, Germany
来源：
PATHOLOGE | 2019年 / 40卷 / 03期
关键词：
D O I：
10.1007/s00292-019-0582-7
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：275 / 275
页数：1
相关论文
共 50 条
  • [1] Predictive value of PD-L1 diagnostics
    Schildhaus, H. -U.
    PATHOLOGE, 2018, 39 (06): : 498 - 519
  • [2] PD-1/PD-L1 Immunohistochemistry in thoracic oncology: or are we? (vol 37, pg 39, 2017)
    Hofman, Paul
    Ilie, Marius
    Lassalle, Sandra
    Long, Elodie
    Bence, Coraline
    Butori, Catherine
    Hofman, Veronique
    ANNALES DE PATHOLOGIE, 2017, 37 (04) : 344 - 344
  • [3] Erratum zu: Der prädiktive Wert der PD-L1-DiagnostikErratum to: Predictive value of PD-L1 diagnostics
    H.-U. Schildhaus
    Der Pathologe, 2019, 40 (3): : 275 - 275
  • [4] Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancer
    Sundar, Raghav
    Smyth, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (06): : 495 - 497
  • [5] Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression (vol 128, pg 805, 2018)
    Lin, Heng
    Wei, Shuang
    Hurt, Elaine M.
    Green, Michael D.
    Zhao, Lili
    Vatan, Linda
    Szeliga, Wojciech
    Herbst, Ronald
    Harms, Paul W.
    Fecher, Leslie A.
    Vats, Pankaj
    Chinnaiyan, Arul M.
    Lao, Christopher D.
    Lawrence, Theodore S.
    Wicha, Max
    Hamanishi, Junzo
    Mandai, Masaki
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1708 - 1708
  • [6] HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC
    Funaishi, Kunihiko
    Yamaguchi, Kakuhiro
    Tanahashi, Hiroki
    Kurose, Koji
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Iwamoto, Hiroshi
    Hamada, Hironobu
    Oga, Toru
    Oka, Mikio
    Hattori, Noboru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [7] The Predictive Value of Circulating Exosomal PD-L1 in Cervical Cancer Immunotherapy
    Tang, W.
    Guo, Q.
    Chen, J.
    Wu, Q.
    Zhang, T.
    Wang, Q.
    Zhang, X.
    Xie, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E548 - E549
  • [8] PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy (vol 128, pg 1413, 2018)
    Zamarin, Dmitriy
    Ricca, Jacob M.
    Sadekova, Svetlana
    Oseledchyk, Anton
    Yu, Ying
    Blumenschein, Wendy M.
    Wong, Jerelyn
    Gigoux, Mathieu
    Merghoub, Taha
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (11): : 5184 - 5184
  • [9] PD-L1 copy number gains: a predictive biomarker for PD-1/PD-L1 blockade therapy?
    Inoue, Yusuke
    Osman, Murat
    Suda, Takafumi
    Sugimura, Haruhiko
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S199 - S202
  • [10] PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases (vol 40, pg 647, 2018)
    Garcia-Diez, I
    Hernandez-Ruiz, E.
    Andrades, E.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2019, 41 (07) : 537 - 537
12345